Headache following intracranial neuroendovascular procedures
Headache: The Journal of Head and Face Pain, 04/27/2012Baron EP et al.
Occurrence of post–procedure headache (PPH) was common after intracranial endovascular procedures (IEPs) and especially so with coiling and in women, smokers, and those with anxiety/depression, and was often of longer duration than allowed by current International Classification of Headache Disorders–II criteria. The yield of diagnostic testing was low, and in a small subgroup treatment with triptans or DHE did not cause adverse events in pre/post–coiled aneurysms. Prospective studies are needed to confirm these findings.
Authors conducted a retrospective chart review of adult patients undergoing IEPs.
Bivariate analyses were conducted to compare patients who did and did not develop PPH.
Authors reviewed records pertaining to 372 patients, of whom 263 underwent intracranial coil embolizations, 21 acrylic glue embolizations, and 88 stent placements.
PPH occurred in 72% of coil patients, 33% of glue patients, and 14% of stent patients.
Significant risk factors for post–coil HA were female gender, any pre–coil HA history, smoking, and anxiety/depression.
A pre–stent history of HA exceeding 1 year's duration, and smoking were risk factors for post–stent HA.
A pre–glue history of HA exceeding 1 year was the only risk factor for post–glue HA.
In the small subgroup available for study, treatment with triptans or DHE was not associated with adverse events in pre/post–coiled aneurysms.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.